期刊文献+

充血性心力衰竭患者血清Ⅲ型前胶原氨基端肽检测的临床价值 被引量:3

Clinical Value of Procollagen Type Ⅲ Aminoterminal Peptide Assay in the Serum of Patients With Congestive Myocardial Failure
原文传递
导出
摘要 目的 测定充血性心力衰竭患者血清中的Ⅲ型前胶原氨基端肽 (PⅢP)及层粘连蛋白 (LN)水平 ,探讨其对心肌纤维化的诊断价值。方法 选择 4 4例充血性心力衰竭患者 (心功能Ⅲ级以上 )和正常健康对照者 30例 ,用放射免疫法测定其血清中的PⅢP及LN水平。结果 心力衰竭患者血清中的PⅢP水平明显高于健康对照组 (5 5± 1 1) μg/Lvs (3 8± 1 5 ) μg/L(P <0 0 1) ,心力衰竭患者血清的LN水平明显高于健康对照组 (14 8 0±32 6 ) μg/Lvs (10 2 6± 2 3 2 ) μg/L(P <0 0 1) ,心功能Ⅳ级组血清的PⅢP水平明显高于心功能Ⅲ级组 (5 7± 0 8)μg/Lvs (5 2± 0 6 ) μg/L(P <0 0 5 ) ,心功能Ⅳ级组血清的LN水平明显高于心功能Ⅲ级组 (16 8 3± 2 2 6 ) μg/Lvs(14 6 2± 18 4 ) μg/L(P <0 0 5 )。结论 PⅢP及LN水平的升高可能部分与心肌纤维化有关 ,可在充血性心力衰竭患者的血清中检测出来 。 Objective To detect the serum concentration of procollagen type Ⅲ aminoterminal peptide (PⅢP) and laminin(LN) in patients with congestive heart failure(CHF),in order to explore the value in diagnosis of myocardial fibrosis.Methods In 44 patients with CHF and 30 healthy controls,serum concentration of PⅢP and LN were measured by competitive radioimmunoassay.Results Serum concentration of PⅢP in patients with CHF significantly increased,as compared with normal controls(5 5±1 1)μg/L vs (3 8±1 5)μg/L(P<0 01).Serum concentration of LN in patients with CHF obviously increased,as compared with normal controls(148 0±32 6)μg/L vs (102 6±23 2)μg/L(P<0 01).Serum concentration of PⅢ-P in patients whose cardiac function in class Ⅳ was higher than that in class Ⅲ (5 7±0 8)μg/L vs (5 2±0 6)μg/L(P<0 05).Serum concentration of LN in patients whose cardiac function in class Ⅳ was higher than that in class Ⅲ(168 3±22 6)μg/L vs (146 2±18 4)μg/L(P<0 05).Conclusions Elevation of extracellular matrix turnover can be monitored in the serum by determining the circulation levels of PⅢP and LN associated with myocardial fibrosis and can predict the clinical stage of heart failure
出处 《中国医师杂志》 CAS 2002年第6期641-642,共2页 Journal of Chinese Physician
关键词 心力衰竭 充血性 纤维化 心肌 检测 Congestive heart failure Collagen Fibrosis,myocardial Detection
  • 相关文献

参考文献2

二级参考文献1

共引文献24

同被引文献26

  • 1郑曙云,徐建国,赵振中.参附注射液对大鼠心肌缺血再灌注损伤的影响[J].中国中西医结合杂志,2004,24(6):541-544. 被引量:61
  • 2Zannad F, AIla F, Dousser B, et al. For RALES Investigators. Limita tion of extracelleular matrix turnover may contribute to survival benefit of spironolaetone therapy in patients with congestive heart failure[J].Circulation, 2000,102 : 2700 - 2706.
  • 3Rocha R,Williams GH. Rationale for the use of aldosterone antag- onists in congestive heart failure[J].Drugs, 2002 (62) : 723 - 731.
  • 4Pitt B, Zannad F, Remme WJ,et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure[J]. N Engl J Med,1999(34,1) :709 - 717.
  • 5Maisel AS, Krishnaswamy P, Nowak RM,et al. Rapid measure of B- type natriuretic poptied in the emergency diagnosis of heart failure[J]. N Engl J Med,2002,347(3) :161 - 167.
  • 6Macdonald JE, Kennedy N, Struthers AD. Effects of spironolactone on endothelial function , vascular angiotensin converting enzyme activity,and other prognostic markers in patients with mild heart failure already taking optimal treatment[J]. Heart, 2004,90 : 765 - 770.
  • 7Maisel AS, Krishnaswamy P. Nowak RM,et al. Rapid measure of B-type natriuretic peptide in the emergency diagnosis of heart failure[J]. N Engl J Med,2002,347(3) :161 - 167.
  • 8D'Aloia AP,Aurigemma G. Serum levels of carbohydrate antigen 125 in patiants with chronic heart failure:Relation to clinical sever- ity, bemodynamie and doppler echocardiographic abnormalities,and short - term prognosis[J]. J AM Coll Cardiol,2003,41(10) : 1805 - 1811.
  • 9Kosar NT, Zacharos TD, Kontogianni DD,et al. The significance of CA125 levels in patients with chronic heart failure. Correlation with clinical and echocardiographic parameters[J]. Eur J Heart Fail, 2005,7(2) : 199 - 203.
  • 10Kosar F, Aksoy Y, Ozguntekin G,et al. Relationship between cyto- kines and tumour markers in patients with chronic heart failure [J]. Eur J Heart Fail,2006,8(3) :270- 274.

引证文献3

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部